These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30762787)

  • 1. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Sun Q; Jia Q; Song L; Duan L
    Medicine (Baltimore); 2019 Feb; 98(7):e14513. PubMed ID: 30762787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis.
    Ju X; Jiang Z; Ma J; Yang D
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.
    Calderon G; Patel C; Camilleri M; James-Stevenson T; Bohm M; Siwiec R; Rogers N; Wo J; Lockett C; Gupta A; Xu H; Shin A
    J Clin Gastroenterol; 2022 Mar; 56(3):234-242. PubMed ID: 33780215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
    Treem WR; Ahsan N; Kastoff G; Hyams JS
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):280-6. PubMed ID: 8890079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients.
    Sun QH; Liu ZJ; Zhang L; Wei H; Song LJ; Zhu SW; He MB; Duan LP
    J Dig Dis; 2021 May; 22(5):246-255. PubMed ID: 33822477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 7. The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome.
    Tian Z; Zhuang X; Luo M; Yin W; Xiong L
    BMC Gastroenterol; 2020 Mar; 20(1):73. PubMed ID: 32178625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis.
    Luo M; Zhuang X; Tian Z; Xiong L
    BMC Gastroenterol; 2021 Jan; 21(1):14. PubMed ID: 33407171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome.
    Fredericks E; Theunissen R; Roux S
    Turk J Gastroenterol; 2020 Dec; 31(12):840-847. PubMed ID: 33625995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
    Zhuang X; Li T; Li M; Huang S; Qiu Y; Feng R; Zhang S; Chen M; Xiong L; Zeng Z
    Inflamm Bowel Dis; 2019 Oct; 25(11):1751-1763. PubMed ID: 31498864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome.
    Waseem MR; Shin A; Siwiec R; James-Stevenson T; Bohm M; Rogers N; Wo J; Waseem L; Gupta A; Jarrett M; Kadariya J; Xu H
    Clin Transl Gastroenterol; 2023 Jan; 14(1):e00541. PubMed ID: 36227781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome.
    Ringel-Kulka T; Choi CH; Temas D; Kim A; Maier DM; Scott K; Galanko JA; Ringel Y
    Am J Gastroenterol; 2015 Sep; 110(9):1339-46. PubMed ID: 26303129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis.
    Gargari G; Mantegazza G; Taverniti V; Gardana C; Valenza A; Rossignoli F; Barbaro MR; Marasco G; Cremon C; Barbara G; Guglielmetti S
    Gut Microbes; 2023 Dec; 15(2):2274128. PubMed ID: 37910479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.
    Gargari G; Taverniti V; Gardana C; Cremon C; Canducci F; Pagano I; Barbaro MR; Bellacosa L; Castellazzi AM; Valsecchi C; Tagliacarne SC; Bellini M; Bertani L; Gambaccini D; Marchi S; Cicala M; Germanà B; Dal Pont E; Vecchi M; Ogliari C; Fiore W; Stanghellini V; Barbara G; Guglielmetti S
    Environ Microbiol; 2018 Sep; 20(9):3201-3213. PubMed ID: 29749705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome.
    Wang Y; Hu Y; Shi P
    BMC Gastroenterol; 2024 Jul; 24(1):217. PubMed ID: 38970007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.
    Shaidullov IF; Sorokina DM; Sitdikov FG; Hermann A; Abdulkhakov SR; Sitdikova GF
    BMC Gastroenterol; 2021 Jan; 21(1):37. PubMed ID: 33499840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of
    Chen L; Xu WL; Pei LX; Wu XL; Geng H; Guo J; Sun JH
    Zhongguo Zhen Jiu; 2021 Feb; 41(2):137-41. PubMed ID: 33788460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.
    Tanaka Y; Yamashita R; Kawashima J; Mori H; Kurokawa K; Fukuda S; Gotoh Y; Nakamura K; Hayashi T; Kasahara Y; Sato Y; Fukudo S
    J Gastroenterol; 2022 Oct; 57(10):748-760. PubMed ID: 35908139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.